Skip to content

Exploring Multidimensional Trajectories in People With Low Back Pain

Exploring Multidimensional Trajectories in People With Low Back Pain

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07176845
Enrollment
600
Registered
2025-09-16
Start date
2025-09-15
Completion date
2028-05-31
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Low Back Pain, Chronic Low Back Pain (CLBP)

Keywords

low back pain, LBP, spinal motion, spine, disability, motor behavior, physical activity, pain-related fear, psychological factors

Brief summary

Low back pain (LBP) is a major health problem in Switzerland and worldwide. Globally, LBP remains the leading cause of years lived with disability and its incidence and associated socioeconomic consequences are predicted to increase in the coming decades. In Switzerland, the condition is one of the most commonly reported physical complaints and negatively affects quality of life, resulting in significant personal burden and personal financial burden. LBP also generates enormous socioeconomic costs, with both direct and indirect costs estimated to reach billions of Swiss francs in Switzerland annually. Therefore, it is essential that LBP prevention, diagnosis, and management are improved. LBP is a multifactorial condition. Social, psychological and biophysical factors, along with comorbidities and genetic factors, influence LBP development and associated disability. In individuals with LBP, psychological factors, such as pain catastrophizing, are associated with higher pain intensity and developing chronic LBP and the associated disability. Among biophysical factors, altered spinal motor behaviour (e.g. smaller trunk movement amplitude) and reduced physical activity have been observed in LBP patients and suggested to influence LBP. However, exactly how all these factors influence LBP and how they are interrelated remains unclear. In particular, the effect of altered spinal motor behaviour on LBP is not understood. However, altered motor behaviour could play an important role in changing LBP and related disability. Therefore, improving our understanding of the patterns of spinal motor behaviour and the interrelationships with other factors in LBP would increase our understanding of LBP progression and could help improve LBP management. This study consists of a 6-month prospective longitudinal cohort observation of spinal motor behavior, physical activity, psychological factors, pain intensity, and disability in LBP patients (300 acute, 300 chronic LBP). Data collection will occur remotely and the frequency of repeated measures will be daily or weekly, depending on the measure. A custom smart-phone application will be used by participants to collect data on spinal motor behavior, psychological factors, pain intensity, and disability. Physical activity will be monitored using a wearable physical activity tracker. Established trajectories of motor behavior will be investigated for potential interrelations with trajectories of other parameters (e.g. pain, psychological factors, and disability), to explore potential causal effects. In addition, risk factors or predictive factors for certain trajectories of motor behavior and other parameters will be identified. As such, this study will allow us to investigate the temporality of these relationships and identify LBP, and in particular spinal motor behavior, phenotypes.

Interventions

OTHERObservational

This study is observational of nature: multidimensional data is collected and no interventional is imposed

Sponsors

University of Applied Sciences of Western Switzerland
CollaboratorOTHER
University of Zurich
CollaboratorOTHER
University of Southern Denmark
CollaboratorOTHER
Bern University of Applied Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have low back pain (rate their LBP with an intensity of \>0 on a 0-10 numerical pain rating scale at enrollment) * 18 years old or older * be proficient in German, French, or English * own a smartphone that is able to run either Android or iOS (iPhone) apps * own a smartphone that includes accelerometer and gyroscope sensors

Exclusion criteria

* diagnosis of a specific LBP etiology (e.g. fracture, tumoral process, radiculopathy with evidence of neurological deficit or cauda equina) * history of previous spinal fusion surgery, which would influence on motor behavior * presence of any other medical conditions (pathologies, diseases, comorbidities, injuries, surgeries or painful conditions) that could jeopardize the patients' safety, prevent them from performing the spinal motion measurements safely (e.g., risk of falls due to frailty), or influence spinal motion (e.g., Parkinson's disease, stroke) * inability to follow procedures * inability to give consent (e.g. dementia) * owner of a smartphone, not able to run an Android or iPhone application * owner of a smartphone without accelerometer and gyroscope sensors

Design outcomes

Primary

MeasureTime frameDescription
Spinal motion: maximum movement amplitudeUp to 25 weeks from enrollment.Spine motion is recorded during multiple repetitions of several clinically relevant motions (trunk flexion, trunk extension, left/right trunk lateral flexion while standing), as well as a functional motion (picking up a lightweight object from the floor). The motion is measured using the internal inertial sensors of the patient's smartphone. The first main variable of interest is maximum movement amplitude (unit: degrees). Frequency of measurement: weekly during the 25-week study period.
Spinal motion: maximum/average movement velocityUp to 25 weeks from enrollment.Spine motion is recorded during multiple repetitions of several clinically relevant motions (trunk flexion, trunk extension, left/right trunk lateral flexion while standing), as well as a functional motion (picking up a lightweight object from the floor). The motion is measured using the internal inertial sensors of the patient's smartphone. The second main variable of interest is maximum/average movement velocity (unit: degrees/second). Frequency of measurement: weekly during the 25-week study period.
Movement-evoked low back painUp to 25 weeks from enrollment.Movement-evoked low back pain (pain during movement) will be scored by patients on an 11-point numerical pain rating scale (0-10; whole-point, with 0 being 'no pain' and 10 'the worst pain you can imagine'), for each spinal motion separately, directly after performing each movement. Frequency of measurement: weekly during the 25-week study period.
Psychological factors: movement pain-related fearUp to 25 weeks from enrollment.Pain-related fear will be assessed for each movement being measured, using an 11-point numerical rating scale (0-10; whole-point), with 0 being 'not harmful at all' and 10 'extremely harmful' (adapted from Photograph Series of Daily Activities-Short Electronic Version; PHODA-SeV). Frequency of measurement: weekly during the 25-week study period.
Psychological factors: task-specific pain-related fearUp to 25 weeks from enrollment.Item four from the Photograph Series of Daily Activities-Short Electronic Version (PHODA-SeV), which shows a person lifting a pot, will be used to assess task-specific pain-related fear. Participants rate their fear on an 11-point numerical rating scale (0-10; whole-point), with 0 being 'not harmful at all' and 10 'extremely harmful'. Frequency of measurement: weekly during the 25-week study period.
Psychological factors: fear avoidance beliefs related to physical activityUp to 25 weeks from enrollment.The physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ) will be used to assess fear avoidance beliefs related to physical activity. Frequency of measurement: weekly during the 25-week study period.
Psychological factors: pain catastrophizingUp to 25 weeks from enrollment.Pain catastrophizing will be assessed using the Daily Pain Catastrophizing Scale (Daily PCS). Frequency of measurement: weekly during the 25-week study period.
Psychological factors: self-efficacyUp to 25 weeks from enrollment.Self-efficacy will be measured using the 2-item short form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Frequency of measurement: weekly during the 25-week study period.
Psychological factors: stressUp to 25 weeks from enrollment.Stress across the last 24 hours will be assessed using the 11-point stress numerical rating scale (0-10, whole-point, with 0 being 'no stress' and 10 being 'worst stress imaginable'). Frequency of measurement: weekly during the 25-week study period.
Physical activity: heart rateUp to 25 weeks from enrollment.Physical activity is measured continuously using a well-established, wrist-worn activity tracker. The first main variable of interest is heart rate (unit: beats per minute). Frequency of measurement: continuously during the 25-week study period.
Physical acitivity: step countUp to 25 weeks from enrollment.Physical activity is measured continuously using a well-established, wrist-worn activity tracker. The second main variable of interest is step count (unit: number of steps). Frequency of measurement: continuously during the 25-week study period.
Low back pain intensityUp to 25 weeks from enrollment.Average low back pain intensity, in the last 24 hours, will be scored by patients on an 11-point numerical pain rating scale (0-10; whole-point), with 0 being 'no pain' and 10 'the worst pain you can imagine'. Frequency of measurement: daily during the 25-week study period.
Disability: general level of disability (1)Up to 25 weeks from enrollment.General level of disability will be rated by patients using an 11-point numerical rating scale (0-10; whole-point, with 0 'not at all', 5 'moderate limitation', 10 'totally limited'). Frequency of measurement: weekly during the 25-week study period.
Disability: general level of disability (2)Up to 25 weeks from enrollment.General level of disability will also be rated by patients using the Roland-Morris Disability Questionnaire (RMDQ). Frequency of measurement: 6-weekly during the 25-week study period.
Disability: lift-specific disabilityUp to 25 weeks from enrollment.The LBP impact on the patient's ability to lift over the past 24 hours will be assessed using one single-item question and rated using an 11-point numeric rating scale (0-10; whole-point, with 0 being 'not al all', 5 'moderate limitation', 10 'totally limited'). Frequency of measurement: weekly during the 25-week study period.

Secondary

MeasureTime frameDescription
Basic medical status: depressionAt enrollmentData on depression will be collected using a questionnaire on an 11-scale (0-10, whole-point) numerical rating scale, with 0 being 'never' and 10 'all the time'.
Basic medical status: stressAt enrollmentData on stress will be collected using the perceived stress scale 4 questionnaire, with for each of the four questions a 5-point scale (0-4, whole-point, with 0 being 'never' and 4 'very often').
Patient demographics: sexAt enrollmentData on sex (female, male, intersex) will be collected using a questionnaire.
Basic medical status: neuropathic painAt enrollmentData on neuropathic pain symptoms will be collected using the first two questions of neuropathic pain diagnosis questionnaire (DN4). For both questions, participants select symptoms from a list, with each selected symptom scored as +1, with a total score of larger than or equal to 3 indicating neuropathic pain.
Basic medical status: medication and treatmentAt enrollmentData on medication as well as previous and current treatment will be collected using a questionnaire
Patient demographics: genderAt enrollmentData on gender (woman, man, non-binary, a term not listed, I am questioning/not sure) will be collected using a questionnaire.
Patient demographics: occupational statusAt enrollmentData on occupational status will be collected using a questionnaire.
Patient demographics: occupationAt enrollmentData on current or recent occupation will be collected using a questionnaire.
Patient demographics: work satisfactionAt enrollmentData on work satisfaction (very unsatisfied; unsatisfied; neutral; satisfied; very satisfied; this is not relevant to me) will be collected using a questionnaire.
Patient demographics: work expectationAt enrollmentData on work expectation ('I think I will be able to do my regular job, without any restrictions, 4 weeks from now' and 'I think I will be able to do my regular job, without any restrictions, 3 months from now'; on a 7-point scale, 0-6 with 0 being 'unlikely' and 6 'definitely') will be collected using a questionnaire.
Patient demographics: highest educationAt enrollmentData on highest education will be collected using a questionnaire.
Patient anthropometry: body massAt enrollmentPatient body mass (unit: kg) will be collected using a questionnaire
Patient anthropometry: heightAt enrollmentPatient height (unit: m) data will be collected using a questionnaire
Basic low back pain history: durationAt enrollmentData on duration of low back pain symptoms will be collected using a questionnaire
Basic low back pain history: otherAt enrollmentData on location and previous episodes of low back pain symptoms, and other diagnoses or previous surgeries will be collected using a questionnaire.
Low back pain beliefsAt enrollmentData on low back pain beliefs will be collected using the BackPAQ questionnaire.
Basic medical status: smoking statusAt enrollmentData on smoking status (yes; no, not anymore; no, never) will be collected using a questionnaire
Basic medical status: comorbiditiesAt enrollmentData on comorbidities will be collected using a questionnaire
Basic medical status: anxietyAt enrollmentData on anxiety will be collected using a questionnaire on an 11-point scale (0-10, whole-point) numerical rating scale, with 0 being 'not at all' and 10 'quite anxious'.

Contacts

Primary ContactStefan Schmid, Prof. Dr.
stefan.schmid@bfh.ch+41 31 848 37 96

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026